🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,064 results for “BRIGHT” Clear

  1. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    approved small molecule active

    1 trial

  2. Propranolol

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    1 trial

  3. Quetiapine and placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Disorder

    approved small molecule completed

    1 trial

  4. Regional Anesthesia

    BRIGHT MINDS BIOSCIENCES INC.

    Inguinal Hernia

    approved small molecule completed

    1 trial

  5. Reinforcement Based Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    approved other completed

    1 trial

  6. Scheduled Gradual Reduction + Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    approved other terminated

    1 trial

  7. Short Cycle Antiretroviral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other completed

    1 trial

  8. Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion , DENOSUMAB, Sodium Fluoride (18F) Life Radiopharma 0,1 - 4 GBq/ml solution injectable

    Disc Medicine

    Fibrous dysplasia/McCune-Albright syndrome

    approved small molecule active

    1 trial

  9. Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]

    BRIGHT MINDS BIOSCIENCES INC.

    HEPATITIS C (HCV)

    approved small molecule active

    1 trial

  10. Sofosbuvir/velpatasvir (Epclusa®)

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    approved small molecule completed

    1 trial

  11. Standard clinical care first, followed by standard clinical care and varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved small molecule completed

    1 trial

  12. Stimulant or sedative

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  13. Thoracic epidural (ropivicaine, fentanyl)

    BRIGHT MINDS BIOSCIENCES INC.

    Pectus Excavatum

    approved small molecule completed

    1 trial

  14. Transdermal Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule terminated

    1 trial

  15. Transdermal nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  16. Vaccination to prevent hepatitis B virus infection

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B

    approved mab completed

    1 trial

  17. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Parkinson's Disease

    approved small molecule terminated

    1 trial

  18. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule terminated

    1 trial

  19. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    3 trials

  20. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    2 trials

  21. Video directly observed therapy with contingency management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other active

    1 trial

  22. Web-based smoking cessation program

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved other completed

    1 trial

  23. XR-B (SUBLOCADETM)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    approved small molecule completed

    1 trial

  24. Xinnaoning Capsule

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Stable Angina Pectoris

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources